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ABSTRACTSResults: The cohort comprised of 19 men and 23 women. The mean age of
patients was 53.23 years. Theywere all unilateral adrenalectomies. Twenty
were left sided procedures and twenty twowere right sided. The diagnoses
were Conn's syndrome in 18 patients, Cushing's syndrome in 4 patients,
Non-functioning adenoma in 11 patients, Pheochromocytoma in 5 pa-
tients, Metastatic lesions in 2 patients. The average tumour size was
34.65mm. The mean operating timewas 95.36minutes. The mean hospital
stay was 4.4 days. One patient required intraoperative blood transfusion.
The morbidity rate was 19% (n¼8). There was no mortality. The open
conversion rate was 2.38% (n¼1).
Conclusions: Laparoscopic adrenalectomy as conﬁrmed in other pub-
lished series is safe and effective. It involves shorter hospital stay. Com-
plications are mild and mortality rare when experienced surgeons are
involved.
0180: TESTICULAR TORSION: A COMPARATIVE AUDIT OF OPERATIVE
PRACTICES IN SOUTH YORKSHIRE
Marcus Cumberbatch 2, Gemma McKenzie 2, Hanif Shiwani 1. 1Barnsley
District General Hospital, South Yorkshire, UK; 2Royal Hallamshire Hospital,
South Yorkshire, UK.
Introduction: Acknowledged by the European Association of Urologists,
there is no set guideline for the operative approach in patients presenting
with the Urological emergency testicular torsion.
Methods: We use recommendations from a paper by Pearce et al 2002 to
compare the practices of General Surgeons at a District General Hospital, and
Urological Surgeons fromaCentral TeachingHospital. Bestpractice in all cases
of testicular torsion included bilateral ﬁxation at 3 points or more, with non-
absorbable sutures, and concomitant excision of the testicular appendage. In
all cases of negative exploration orchidopexy was not advocated.
Results: Our ﬁndings in 69 cases from two hospitals over a two-year
period show that operative practices are similar between the disciplines
and we are matching the recommendations. However, a high proportion
of negative explorations are still resulting in ﬁxation, which is not
required. A higher proportion of General Surgeons are using absorbable
sutures.
Conclusions: Surgical trainees are in front line to receive this emergency
and there is a need to provide a national guideline to set standards and
ensure best patient care. We are constructing an intranet operative
guideline on scrotal exploration for trainees.
0195: OUR INITIAL EXPERIENCE OF MINIMALLY INVASIVE SURGERY
(LAPAROSCOPIC AND ROBOTIC) IN THE MANAGEMENT OF SMALL
RENAL MASSES
Karen Randhawa, Robin Weston, Philip Cornford. Royal Liverpool University
Hospital, Merseyside, UK.
Aims: For patients with primary tumour less than 4cm, nephron sparing
surgery is preferred to preserve renal parenchyma and function thereby
decreasing the risk of chronic kidney disease. We reviewed our surgical
outcomes following NSS by laparoscopic and robot techniques.
Method: Retrospective review of 12 consecutive patients who underwent
NSS between 2010 and 2012 for renal tumours (laparoscopic and robotic)
were included in the study. Data collected included tumour size, renal
function pre/post surgery, histology and disease free data. Complications
were recorded using Clavien-Dindo classiﬁcation.
Results: Most procedures were robot-assisted, while four were performed
laparoscopically. Median PADUA score was 6.5 with average tumour size of
2.65cms. Warm ischaemia time varied from zero to twenty-two minutes,
with mean length of stay 2.6 days for robotic and 4.65 days for laparoscopic
surgery. Preoperatively average eGFR was 77ml/min/1.732, with post-
operative average of 76ml/min/1.732. 2 patients encountered Grade 1 com-
plications and 2 of Grade 2. 92% of patients had negative surgical margins.
Conclusions: Robot NSS appears to be a safe and technically feasible
approach with shorter length of stay than other operative methods. These
early results suggest good surgical outcomes with reduced perioperative
morbidity and preservation of renal function achievable by minimally
invasive NSS.
0207: THE BENEFICIAL EFFECTS OF ENHANCED RECOVERY PROTOCOL
FOR PATIENTS UNDERGOING RADICAL CYSTECTOMYMohammed Ashraﬁ, Garwi Choy, Mohammed Masaarane. Lancashire
Teaching Hospitals NHS Foundation Trust, Preston, UK.
Aim: Radical Cystectomy is associated with signiﬁcant morbidity and
prolonged inpatient stay. Enhanced recovery protocols (ERP) are periop-
erative care pathways designed to achieve early recovery after surgical
procedures. The aimwas to assess the impact on patient outcome after the
introduction of an ERP for the management of patients undergoing radical
cystectomy.
Method: An ERP was introduced in our hospital and 60 consecutive pa-
tients between March 2010 and February 2012 were compared (ERP¼32
and non-ERP¼28). The primary outcome measures were duration of
inpatient stay, morbidity and mortality. Data were analyzed retrospec-
tively from hospital records.
Results: There was a statistically signiﬁcant reduction in the length of
hospital stay for patients in the ERP group (mean¼16) in comparison to the
non-ERP group (mean¼25; p ¼ 0.016). There was increase rate of post
operative ileus in the non-ERP group (12 vs 6), however this was not
statistically signiﬁcant. The 30 day mortality rate for all groups was 0%.
Conclusions: The introduction of an ERP was associated with signiﬁcantly
reduced hospital stay, with no detrimental effect on morbidity or
mortality.
0217: THE USE OF UROVAXOM IN TREATMENT OF RECURRENT URI-
NARY TRACT INFECTION
Kieran Murphy, Sheilagh Raid. Royal Hallamshire Hospital, Shefﬁeld Teaching
Hospitals, Shefﬁeld, UK.
Acute uncomplicated cystitis is treated with short-term antibiotic therapy,
however recurrent urinary tract infection (UTI) can be a disabling condi-
tion associated with signiﬁcant morbidity.
Aim: We looked at using Urovaxom in reducing frequency of urinary
tract infections. Urovaxom is an oral vaccine containing lyophilized
bacterial lysates of Escherichia coli, for treatment of urinary tract
infections.
Method: We performed retrospective case note review of patients who
received Urovaxom over a 2 year period. Initially given as a 3 month
course, with further doses taken during and for 10 days following an acute
episode of UTI; in conjunction with traditional antibiotic therapy. We are
the ﬁrst UK centre licensed to use this product.
Results: In a group of 10 patients who have used Urovaxom, there was
signiﬁcant improvement in 5 patients, with some improvement in a
further 2 patients. In those patients where symptoms improved there was
less use of antibiotic therapy and perceived improvement in quality of life.
Conclusions: Initial work has shown that in patients with difﬁcult to treat
symptoms, Urovaxom may be beneﬁcial as an adjunct to traditional
treatment, in reducing the number of infections. European Association of
Urology (EAU) guidelines reﬂect this in female patients, although a
consensus is not yet available in males
0268: PATIENT EDUCATION: ARE WE DOING ENOUGH TO ENABLE THEM
TO IMPROVE THEIR OWN OUTCOMES?
Emma Upchurch, Edward Jefferies, Kim Davenport. Cheltenham General
Hospital, Cheltenham, UK.
Aim: Venous thromboembolism (VTE) is a preventable postoperative
complication. The hypercoagulable state following surgery remains for at
least 28 days, thus, prophylaxis should continue to cover this period. The
aim of this audit is to determine if patients are completing the course of
prophylaxis on discharge and, if not, the reasons for this.
Method: Patient compliance and reasons for non-compliance was deter-
mined via retrospective telephone questionnaire for patients who had
undergone major urological surgery between February and May 2012.
Results: 72% of patients were prescribed the appropriate length of VTE
prophylaxis. Of these, only 20% of patients completed the course. The main
reason for failure was lack of understanding.
Conclusion: Despite adequate prescribing, patients failed to complete the
recommended course of prophylaxis, thus, placing them at increased risk
of VTE. The majority of patients did not understand the reasons and, thus,
stopped the 28 day course early. They reported limited information from
medical staff regarding the beneﬁts (and risks) of continuing VTE pro-
phylaxis for 28 days. This audit did not measure the incidence of VTE,
